Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Adherence to Preventive Medications Reduces Risk of Diabetes

Posted: Wednesday, September 13, 2006

Participants who were compliant had a 38.2% reduced risk of developing diabetes.

The DPP investigated the value of intensive lifestyle intervention or metformin in delaying or preventing type 2 diabetes in high-risk individuals with impaired glucose tolerance.

Dr. Elizabeth A. Walker, of George Washington University, Rockville, Maryland, and colleagues examined medication adherence and health outcomes in the metformin and placebo arms of the DPP. They also assessed barriers to adherence and strategies for medication adherence.

A total of 2155 subjects who were randomly assigned to either the metformin or placebo treatment arms were included in the analysis. The overall adherence rates (the proportion of patients taking at least 80% of the prescribed dose) were 71% in the metformin group and 77% in the placebo group.

Among patients taking metformin, older age groups were more adherent than the youngest group (p = 0.01).

"Among both metformin and placebo arms, the most commonly reported barriers to taking DPP medication as prescribed were forgetting to take doses (22%), adverse effects (8%), and disruption of routines (8%)," Dr. Walker's team found. Overall, 15% of women and 10% of men reported adverse effects in the metformin group.

Participants who reported multiple strategies to take medications had increased odds of adherence (odds ratio 2.69, p < 0.0001).

Compared to patients who were adherent to placebo, those adherent to metformin had a 38.2% reduced risk of developing diabetes (p < 0.0003), the investigators report.

They conclude, "Our finding that the level of medication adherence predicted the primary outcome of diabetes lend support for future development and evaluation of brief, practical medication adherence interventions for primary care settings."

 

 

Source: Diabetes In Control: Diabetes Care 2006;29:1997-2002

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement